Voloridge Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-85,116
Closed -$3.37M 1376
2024
Q4
$3.37M Sell
85,116
-163,461
-66% -$6.19M 0.01% 861
2024
Q3
$8.46M Buy
248,577
+167,454
+206% +$4.71M 0.03% 631
2024
Q2
$1.76M Sell
81,123
-134,092
-62% -$2.82M 0.01% 969
2024
Q1
$4.77M Buy
+215,215
New +$5.25M 0.02% 668
2023
Q4
Sell
-111,635
Closed -$2.49M 1505
2023
Q3
$2.49M Sell
111,635
-105,564
-49% -$2.71M 0.01% 863
2023
Q2
$5.53M Sell
217,199
-152,766
-41% -$3.7M 0.03% 639
2023
Q1
$8.25M Buy
369,965
+29,000
+9% +$701K 0.04% 512
2022
Q4
$8.09M Buy
340,965
+7,741
+2% +$180K 0.05% 493
2022
Q3
$5.53M Sell
333,224
-92,014
-22% -$2.07M 0.03% 623
2022
Q2
$8.46M Buy
425,238
+82,262
+24% +$1.66M 0.04% 503
2022
Q1
$9.46M Buy
342,976
+337,299
+5,942% +$9.65M 0.05% 423
2021
Q4
$234K Sell
5,677
-108,418
-95% -$4.79M ﹤0.01% 1504
2021
Q3
$5.3M Sell
114,095
-176,088
-61% -$7.68M 0.03% 654
2021
Q2
$11.6M Buy
290,183
+274,141
+1,709% +$11.7M 0.08% 356
2021
Q1
$862K Sell
16,042
-15,852
-50% -$913K 0.01% 1067
2020
Q4
$1.56M Buy
+31,894
New +$1.48M 0.01% 822
2019
Q2
Sell
-17,109
Closed -$428K 1095
2019
Q1
$428K Buy
+17,109
New +$327K 0.01% 711

Other funds holding VCYT

Voloridge Investment Management's VCYT Position: Q1 2025 in Review

Voloridge Investment Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 85,116 shares — an estimated $3.37M sold.

Voloridge Investment Management first reported a position in VCYT in Q1 2019 and held it in 17 quarters. The position peaked at $11.6M in Q2 2021. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Voloridge Investment Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 85,116 Veracyte shares in Q1 2025, an estimated $3.37M.
  • Voloridge Investment Management first reported a position in Veracyte in Q1 2019 and held it in 17 quarters.
  • Voloridge Investment Management's Veracyte position peaked at $11.6M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.